Tracon Pharmaceuticals, Inc.
SEC CIK 1394319 · TCON · last insider filing 2024-05-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Theuer Charles | Director · President and CEO | filed 2015 - 2024 |
| Pelletier Saundra L | Director | filed 2020 - 2023 |
| Mattingly Martin A | Director | filed 2015 - 2023 |
| Larue William R | Director | filed 2015 - 2023 |
| Worland Stephen T | Director | filed 2015 - 2023 |
| Twiford J Rainer | Director | filed 2015 - 2023 |
| Lam Carol C. | Director | filed 2021 - 2023 |
| Johnson-Pratt Lisa | Director | filed 2021 - 2023 |
| Walker Paul Edward | Director | filed 2015 - 2020 |
| Wang Theodore T | Director | filed 2018 - 2019 |
| Hozoji Hironori | Director | filed 2015 - 2015 |
| Harada Kenji | Director | filed 2015 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lazar David E. | Chief Business Dev Officer | filed 2024 - 2024 |
| Brown Scott B. | Chief Financial Officer | filed 2019 - 2024 |
| Adams Bonne J. | Chief Operating Officer | filed 2023 - 2023 |
| Wiggins Mark C | Chief Business Officer | filed 2018 - 2022 |
| Bitar Patricia L | CFO | filed 2015 - 2018 |
| Logan H Casey | Chief Business Officer | filed 2015 - 2018 |
| Shazer Ronald L | Chief Medical Officer | filed 2015 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.